*Patients must be physically located in a state where our providers are licensed at the time of prescribing
In adults with overweight or obesity (without diabetes) the semaglutide 2.4 mg dose produced an average weight reduction of about 15% of baseline body weight over ~68 weeks in the STEP 1 trial, a result that surprised many clinicians because it brought pharmacologic outcomes into a range previously associated with surgical interventions
Short-Term Effectiveness of Low Dose Liraglutide in Combination With Metformin Versus High Dose Liraglutide Alone in Treatment of Obese PCOS: Randomized Trial
These findings represent substantial improvements over traditional anti-obesity medications and approach the efficacy levels historically associated with bariatric surgery
Semaglutide is available as both tablets and injections, while tirzepatide is only available as an injection
Back Hendershot, CS, Bremmer, MP, Paladino, B, et al (12 Feb 2025) 'Once-weekly semaglutide in adults with alcohol use disorder: A randomized clinical trial', JAMA Network, 82/4, 395-405.Back 'Scientists pioneer two techniques to combat obesity', The Guardian
